Evidence map›Paper›PMID 35456127›Full record

ReviewPathogens (Basel, Switzerland)2022

Prevention and Control of COVID-19 after Resuming General Hospital Functions.

Jingwen Li, Hanshu Liu, Chao Duan, Lan Chen, Qing Zhang, Xi Fang, Lei Tan, Na Li, Xinyi Wang, Xing Zhang and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jingwen LiDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
Hanshu LiuDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.ORCID 0000-0002-9127-436X
Chao DuanMedical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan 430000, China.
Lan ChenMedical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan 430000, China.
Qing ZhangMedical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan 430000, China.
Xi FangMedical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan 430000, China.
Lei TanMedical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan 430000, China.
Na LiMedical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan 430000, China.
Xinyi WangDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
Xing ZhangMedical Treatment Expert Group for COVID-19, Wuhan Red Cross Hospital, Wuhan 430000, China.
Chunmei LiWuhan Dongxihu District People's Hospital, Wuhan 430000, China.
Zhicheng LinLaboratory of Psychiatric Neurogenomics, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA.
Nian XiongDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.ORCID 0000-0003-1371-0522
Wuhan Red Cross Hospital · CNUnion Hospital · CNHarvard University · USWuhan Dongxihu District People Hospital · CN

Funding

National Natural Science Foundation of China 81873782
6 · The paper itself

Abstract

During the COVID-19 pandemic, many general hospitals have been transformed into designated infectious disease care facilities, where a large number of patients with COVID-19 infections have been treated and discharged. With declines in the number of hospitalizations, a major question for our healthcare systems, especially for these designated facilities, is how to safely resume hospital function after these patients have been discharged. Here, we take a designated COVID-19-care facility in Wuhan, China, as an example to share our experience in resuming hospital function while ensuring the safety of patients and medical workers. After more than 1200 patients with COVID-19 infections were discharged in late March, 2020, our hospital resumed function by setting up a three-level hospital infection management system with four grades of risk of exposure. Moreover, we also took measures to ensure the safety of medical personnel in different departments including clinics, wards, and operation rooms. After all patients with COVID-19 infections were discharged, during the five months of regular function from April to September in 2020, no positive cases have been found among more than 40,000 people in our hospital, including hospital staff and patients.

Indexed as

COVID-19functionhospital managementinfection controlresume

Identifiers

PMID35456127
PMCPMC9032099
OpenAlexW4223414473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.